NameHepatocellular carcinoma (A:I)
DescriptionTwo over-editing sites (Q103R and K96R) of CDK13, modified by ADAR, are more abundant in HCC tumor tissues and are associated with poor prognosis of HCC patients
Related RNA reactionA:I
Found in RNAmRNA
Modified TranscriptCDK13
Mapping TechnologyIllumina HiSeq 3000 sequencing
Quantification techniquesRNAEditor

Enzymes connected to this disease:

Acronym Full name Enzyme Role Organism
ADARB1 Double-stranded RNA-specific editase 1 oncogene Homo sapiens


ID Title Authors Journal Details PubMed Id DOI
1049 CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients. Xiuqing Dong Cell Physiol Biochem [details] 29996118 10.1159/000491656

Copyright © Genesilico - All rights reserved
If you have any advice or suggestions for corrections or improvements, please contact: Andrea Cappannini - lp.vog.bcmii@ininnappaca